CXCL10 and adrenomyeloneuropathy: When compared with healthy controls, the presence of myelopathy in AMN patients was reflected by significantly altered blood levels of CXCL10 (478.4 [344.7–730.1] pg/mL vs 258.8 [186.3–435.9] pg/mL, adj.